Edmond DE Rothschild Holding S.A. cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 39.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,047 shares of the financial services provider’s stock after selling 3,863 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in iShares Biotechnology ETF were worth $1,273,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of IBB. GW&K Investment Management LLC purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $1,621,000. one8zero8 LLC purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at $26,000. Private Advisor Group LLC lifted its stake in shares of iShares Biotechnology ETF by 16.1% during the 3rd quarter. Private Advisor Group LLC now owns 27,403 shares of the financial services provider’s stock valued at $5,769,000 after buying an additional 3,801 shares in the last quarter. Tyche Wealth Partners LLC increased its stake in iShares Biotechnology ETF by 1.9% in the 3rd quarter. Tyche Wealth Partners LLC now owns 3,128 shares of the financial services provider’s stock worth $658,000 after buying an additional 57 shares in the last quarter. Finally, Maxele Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 11.1% in the third quarter. Maxele Advisors LLC now owns 5,285 shares of the financial services provider’s stock worth $1,113,000 after acquiring an additional 530 shares during the period. 62.45% of the stock is currently owned by hedge funds and other institutional investors.
iShares Biotechnology ETF Trading Down 2.1%
iShares Biotechnology ETF stock opened at $199.54 on Friday. The firm’s 50 day moving average price is $208.82 and its 200-day moving average price is $187.68. iShares Biotechnology ETF has a 1 year low of $159.68 and a 1 year high of $222.29.
iShares Biotechnology ETF Cuts Dividend
iShares Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
See Also
- Five stocks we like better than iShares Biotechnology ETF
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
